• 1. 2. Ophthalmic Center of PLA, Wuhan General Hospital of Guangzhou Military Command3. Wuhan General Hospital of Guangzhou Military Command4. Department of Ophthalmology, Renmin Hospital of Wuhan University;
Export PDF Favorites Scan Get Citation

Objective  To observe the efficacy of photodynamic therapy for vitelliform macular dystrophy(VMD) with choroidal neovascularization(CNV). Methods  The clinical data of 7 patients (7 eyes) of VMD with CNV who had undergone photodynamic therapy (PDT) were retrospectively analyzed. The patients were 4 males and 3 females, aged from 20 to 54 years. The patients received the examinations of best corrected visual acuity (BCVA), slitlamp microscopy, fundus photography, fluorescein angiography (FFA), indocyanine green angiography (ICGA), spectral domain OCT(SD-OCT), electrooculogram(EOG)and electroretinogram (ERG)before and after PDT. The BCVA ranged from finger counting to 0.6. Retinal edema and the subretinal fluid were observed. The mean thickness of central retina was (506.00 plusmn;30.71)  mu;m. PDT was performed according to the standard treatment. The follow-up period ranged from 2 to 11 months with the mean of 6.3 months. The changes of BCVA, CNV and side effects were observed after treatment. Results  BCVA improved in all patients ranging from 0.12 to 1.0. The regression of the CNV and resolution of the subretinal fluid were observed by FFA, ICGA and SD-OCT after PDT. The mean thickness of central retina was reduced to (401.00 plusmn;52.22)  mu;m. There was no PDTassociated ocular or systemic side effect. Conclusions  PDT is an effective and safe treatment for VMD with CNV. It may improve or stabilize the visual acuity. 

Citation: ,YiQiao XING,Yanping Song,ZhongShan CHEN,LI Lu. Clinical observation of photodynamic therapy for vitelliform macular dystrophy with choroidal neovascularization. Chinese Journal of Ocular Fundus Diseases, 2011, 27(6): 538-541. doi: Copy